Clinical Trial Update: Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating positron emission tomography using hormone receptor ligands in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: COMPLETED